Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. COCP
COCP logo

COCP Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Cocrystal Pharma Inc (COCP) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
1.000
1 Day change
-2.91%
52 Week Range
2.670
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Cocrystal Pharma Inc (COCP) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock shows weak financial performance, no significant positive catalysts, and lacks clear technical or trading signals to suggest an immediate buying opportunity. It is better to hold off on investing in this stock for now.

Technical Analysis

The MACD is negatively expanding below 0, indicating bearish momentum. RSI is neutral at 41.415, and moving averages are converging, showing no clear trend. The stock is trading near its support level (S1: 1.021), but there is no strong indication of a reversal.

Positive Catalysts

  • NULL identified. There is no recent news or significant trading activity from insiders or hedge funds.

Neutral/Negative Catalysts

  • The stock has shown a consistent decline in price (-4.63% in regular market and -2.78% in pre-market). Financial performance is weak, with a significant drop in net income (-58.51% YoY) and EPS (-61.22% YoY).

Financial Performance

In Q3 2025, revenue remained at 0 with no growth. Net income dropped significantly to -$2,049,000 (-58.51% YoY), and EPS declined to -0.19 (-61.22% YoY). Gross margin remains at 0 with no improvement.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No recent analyst rating or price target changes available.

Wall Street analysts forecast COCP stock price to rise
1 Analyst Rating
Wall Street analysts forecast COCP stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 1.000
sliders
Low
10
Averages
10
High
10
Current: 1.000
sliders
Low
10
Averages
10
High
10
H.C. Wainwright
H.C. Wainwright
Buy
downgrade
$7 -> $6
AI Analysis
2025-06-21
Reason
H.C. Wainwright
H.C. Wainwright
Price Target
$7 -> $6
AI Analysis
2025-06-21
downgrade
Buy
Reason
H.C. Wainwright lowered the firm's price target on Cocrystal Pharma to $6 from $7 and keeps a Buy rating on the shares. The firm says CDI-988 demonstrated "further promise" via activity against emergent norovirus variants. It cites anticipated equity dilution for the target cut.

People Also Watch